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Introduction
Medicinal plants have been continuously used for thou-
sands of years to treat various disorders and to prevent a 
number of animal and human diseases (bacteria, viruses, 
fungi, etc.) (1,2). The knowledge of various medicinal 
plant properties has been transmitted all over the world. 
It has been reported that the active constituent is respon-
sible for immunopharmacological properties of medici-
nal plants so that some of them are continuously used 
throughout the world for different purposes (3,4). 
There are a large number of medicinal plant products, po-
tentially able to control various diseases and also used for 
specific case of disease treatment (1). For the last twenty 
years, lot of work was done on many medicinal plant prod-
ucts with description of their chemical constituents in the 
form of primary and secondary metabolites (2,3). These 
metabolites could be isolated using various types of quali-
tative and quantitative based assays, leading to understand 
the mechanism and correlation between these metabolites 
and disease model studies (5). Thus, the present work was 
focused on Santalum album, as one of medicinal plants, 
with emphasis on its antimicrobial properties in human 
peripheral blood mononuclear cells (PBMCs).
Newcastle disease virus (NDV, single-stranded RNA vi-
rus) belongs to the family Paramyxoviridae and genus 
Aulavirus with helical capsid symmetry. Till now, NDV 
disease still burdens for the poultry industry with several 
consequences including an increase in mortality rates (5). 
The only control method for NDV disease is through vac-
cination but it does not provide hundred percent protec-
tion. Thus there is a need to search for those medicinal 
plants to control the burden of NDV disease.
One of the medicinal plant, Santalum album (commonly 
known as chandan) in the family Santalaceae, is usually 
found in India, china, Indonesia and Philippines (6,7). 
Santalum album, is a widely plant commonly found in In-
dia especially parts of Karnataka and adjoining districts of 
Maharashtra, Tamil Nadu and Andhra Pradesh in India. 
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Introduction: In order to scrutinize the anti-microbial and anti-inflammatory agents, many 
research groups have focused their works on the field of immunopharmacology. Thus, the current 
study aimed to evaluate the immunopharmacological activity of aqueous root extract of Santalum 
album against Hepatitis B surface antigen (HBsAg) and Newcastle disease virus (NDV) on human 
peripheral blood mononuclear cells (PBMCs). 
Methods: Variable doses of aqueous root extract of Santalum album (0.5-30 mg/ml, 50 µl) were 
prepared using phosphate buffered saline (PBS) and tested for proliferation assay, nitric oxide 
production and CD14 monocyte surface marker using flow cytometry. 
Results: Aqueous root extract of Santalum album inhibited proliferation, nitric oxide production 
and CD14 monocyte surface marker at higher doses.
Conclusion: Aqueous root extract of Santalum album possesses both anti-inflammatory as well as 
antiviral activities and might be used for these purposes. 
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Actually, this plant is being exploited for various purposes 
especially sandalwood oil is obtained mostly by steam dis-
tillation of its root and heartwood (8,9) with a number of 
medicinal uses e.g. treatment of many other ailments like 
diarrhea along with bleeding, intrinsic hemorrhage, in-
flamed hemorrhoids (piles), eye infections, inflammation 
of the umbilicus, hiccoughs initial phase of pox, and ur-
ticaria (10,11). The current study was focused on the im-
munopharmacological activity of Santalum album on hu-
man PBMCs against Hepatitis B surface antigen (HBsAg) 
and NDV.
Materials and methods
Assemblage and composition of plant material 
The fresh roots of Santalum albumin were collected from 
the garden of Vidya Pratishthan’s in the morning, between 
January and February 2015 in Baramati region, District 
Pune, Maharashtra, India. Afterwards, the fresh roots 
were washed in tap water and then with distilled water to 
remove dust and finally dried in a shady area. The plant 
roots were macerated with liquid nitrogen to prepare a 
fine powder. This powder was used for subsequent immu-
nopharmacological assays.
Phytochemical screening and extraction
Different qualitative and quantitative based assays were 
carried out in order to determine the presence of second-
ary metabolites. Qualitative based assays revealed aqueous 
root extracts of Santalum album and the presence of Sapo-
nin (foam test); terpenoids (acetic anhydride test) and fla-
vonoids (alkaline reagent test).
Collection of NDV samples
NDV Samples of suspected birds were collected under 
the programme of Biovillage scheme, Vidya Pratishthan’s 
School of Biotechnology. 
Specific pathogen free chicken eggs were purchased from 
Venkys India Ltd. The allantoic cavity route of embryo-
nated (9-11 day old) chicken eggs was used for isolation 
and propagation of NDV from field samples (5). These 
eggs were observed in dark (using candle) at regular in-
tervals and bigger sized embryos (air cell and area without 
blood vessels) selected for inoculation. After disinfection 
of egg shells with spirit, 0.2 ml of supernatant was inocu-
lated at 45° angle into embryonated chicken eggs. Embryo 
motility was observed every 10 hours by candling. After 
the death of embryos, amnio-allantoic fluid was harvested 
and checked for presence of virus. This was determined 
through haemagglutination test (128 HA titre value).
PBMC proliferation assay and nitric oxide production 
using HBsAg and NDV
EDTA anti-coagulant human blood samples were collect-
ed from Mangal Pathology Laboratory, Maharashtra, In-
dia and scrutinized at the VSBT, Baramati, Maharashtra, 
India, between January to February 2015. 
PBMCs were separated by means of density gradient cen-
trifugation and cultured with variable doses of aqueous 
root extracts (0.5-30 mg/ml, 50 µl) of Santalum album 
along with or without HBsAg (20 µg/ml, 10 µl) and NDV 
(1:80 dilution, 10 µl). Incubate 96-well plates for 48 hours 
at 37°C. HBsAg and NDV used as standard for these stud-
ies. Centrifuging the plates was done at 2500 rpm for 10 
minutes at 4°C with collecting the supernatant for the esti-
mation of nitric oxide production through Griess reagent. 
Afterwards, fresh complete medium was added into the 
96-well plates. Again, incubating the plates for another 
4 hours along with (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium-bromide; 5 mg/ml, 10 µl) continued. 
After incubation, the plates were suddenly centrifuged 
with discarding the supernatant, collecting the pellet and 
finally dispersing in dimethyl sulphoxide (DMSO) solu-
tion. The optical density was measured at 570 nm (12,13).
After preincubation of PBMC (105 cells/ml) with or with-
out HBsAg and NDV for 48 hours the supernatant (as 
mentioned above) was collected for estimation of nitric 
oxide production. Briefly, 50 μl of untreated and treated 
PBMC cell culture medium along with HBsAg/NDV was 
assorted with 50 μl of Griess reagent (1% sulfanilamide 
and 0.1% naphthyl ethylenediamine dihydrochloride 
[NED] in 2.5% phosphoric acid). For this experiment, 
Roswell Park Memorial Institute medium (RPMI) con-
taining 10% fetal bovine serum was used as a blank fol-
lowed by incubation of 96-well plates at room temperature 
for 10-15 minutes. After incubation, absorbance at 540 
nm was measured in a microplate reader (14,15).
Estimation of CD14 monocyte surface marker by flow 
cytometry
In another set of experiments, human PBMCs were cul-
tured with serial dilutions of aqueous root extracts of 
Santalum album along with or without HBsAg (20 µg/ml, 
10 µl)/NDV (1:80 dilution, 10 µl) for 48 hours in 96-well 
plates. After incubation, samples of the PBMCs treated 
with or without HBsAg/NDV were collected and stained 
with CD14 FITC (3 µl) monoclonal antibody. The samples 
were then incubated, lysed and washed with phosphate 
buffered saline (PBS). Finally, the samples were prepared 
for flow cytometric analysis. The resulting stained cell pel-
let was resuspended in 2000 μl of PBS and run on a FACS 
Calibur flow cytometer (16,17).
Statistical analysis
All values were mentioned as mean ± SE. Data was rep-
resented by one-way analysis of variance (ANOVA) test 
(Bonferroni multiple comparison test).
Results
PBMC proliferation assay 
The effect of variable doses of aqueous root extract of San-
talum album on PBMC proliferation assay with or without 
HBsAg and NDV using MTT is shown in Figure 1. The 
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aqueous extract showed a dose-dependent decrease in the 
proliferation assay with or without HBsAg/NDV as com-
pared to control. Also, there was a significant enhance-
ment of PBMC proliferation as compared to control. 
Nitric oxide estimation 
The observed effect of variable doses of aqueous root ex-
tract in the cell culture medium of PBMC along with or 
without HBsAg/NDV is shown in Figure 2. The aqueous 
root extract showed a significant decrease in nitric oxide 
production at higher doses with or without HBsAg/NDV 
as compared to control. There was a significant enhance-
ment of nitric oxide production as compared to control. 
CD14 monocyte surface marker
The effect of aqueous root extract of CD14 monocyte 
surface marker on PBMC with or without HBsAg/NDV 
is shown in Figure 3. There was a significant decrease in 
CD14 monocyte surface marker at higher doses as com-
pared to control.
Discussion
The prime objective of our study was to investigate the 
aqueous root extract of Santalum album for in vitro pro-
liferation, nitric oxide production and CD14 monocyte 
surface marker on human PBMC using HBsAg and NDV, 
in order to validate the potential use of this aqueous root 
extract as a tool in screening for anti-inflammatory and 
anti-microbial effects on the immune system. 
As per the literature survey, there are a number of im-
munopharmacological studies related to medicinal plants 
which have already been done using non specific antigens 
on humoral and cell mediated immune response (18). 
These studies are a matter of great interest for many im-
munopharmacologists. For instance, one of the medicinal 
plant namely, Santalum album shows anti-inflammatory 
(reduction in HBsAg) as well as anti-microbial (inhibitory 
effect of NDV) activities at higher doses as compared to 
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Figure 1. Effect of variable doses of aqueous root extract of Santalum album on HBsAg and NDV in human PBMC. PBMC were 
cultured with or without optimized dose of HBsAg and NDV along with variable doses of aqueous root extract (0.5, 1, 10 and 30 mg/ml, 
50 µl) or NDV/HBsAg alone. After 3 days, proliferation was measured by MTT assay. The results are presented as Mean ± S.E. *P < 0.05, 
**P < 0.01, ***P < 0.001 as compared to control.
Figure 2. Estimation of nitric oxide production (NO) from 
human PBMC. The supernatant nitrite concentration was 
determined by Griess reagent after 48 h culture of cells in 
presence of with or without HBsAg and NDV along with variable 
doses of aqueous root extract (0.5, 1, 10 and 30 mg/ml, 50 µl) or 
NDV/HBsAg alone. Values are expressed as Means ± S.E. The 
difference between the control and treated groups is determined 
by One-way ANOVA test (Bonferroni multiple comparison test). *P 
< 0.05; **P < 0.01; ***P < 0.001.
Figure 3. Flow cytometric analysis of aqueous root extract 
extracted from Santalum album on CD14 monocyte surface 
marker. PBMC were treated with variable doses of aqueous root 
extract (0.5, 1, 10 and 30 mg/ml, 50 µl) along with or without NDV/
HBsAg and then lysed and wash the cells with PBS and analyzed 
through flow cytometer (FACS, Calibur) using forward and side 
scatter gating applied for data acquisition of 10000 events of cell 
populations representing different phenotypes analyzed using cell 
quest software.
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control and standard HBsAg/NDV. 
One of the parameters interconnected with our immune 
system i.e. nitric oxide production, provides reliable infor-
mation whether the aqueous root extract shows inhibitory 
or stimulatory effect with respect to PBMC proliferation 
assay and CD14 monocyte surface marker. The criteria for 
selecting this parameter i.e. nitric oxide (as a fundamental 
signaling agent), regulates various immunopharmacologi-
cal functions and serves as a potent mediator of inflam-
mation, bacteria or viral disease burden and cytotoxicity 
(14,15). The findings of the preliminary phytochemical 
investigations of the aqueous root extract of Santalum al-
bum and the results of anti-inflammatory activity against 
HBsAg are shown in the respective figures with anti-viral 
activity against NDV. The results indicate that aqueous 
root extraction of Santalum album shows a dosage-de-
pendent relationship. 
The capacity to elicit a decline in T cell immunity can be 
shown by the CD14 monocyte surface marker. This is de-
termined through flow cytometry and generally used for 
measuring the properties of the cell suspended in a stream 
of fluid when passing through one, two or three lasers. It is 
also used for measuring the immunophenotyping i.e. de-
tection of cell surface molecules such as cluster of differen-
tiation (CD), cell cycle analysis, cell viability, total protein, 
enzyme activity, gene expression etc. (16,17). The results 
indicate that aqueous root extract could significantly re-
duce the CD14 count in human PBMC exposed to HBsAg 
and NDV. The results of our immunopharmacological 
studies on human PBMC after exposing with HBsAg and 
NDV suggest that the aqueous root extract shows anti-
inflammatory as well as anti-viral effect on human PBMC. 
Conclusion
This study suggests that the aqueous root extract of San-
talum album significantly inhibits the production of pro-
liferation assay, nitric oxide production and CD14 mono-
cyte surface marker when using HBsAg and NDV. Further 
investigations of the aqueous root extract should be done 
through in vivo assessment for immunopharmacological 
studies in mice models with identification of the major ac-
tive components responsible for anti-microbial and anti-
inflammatory activities. 
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